Skip to content
Aperlena

Germany - Medicines - Open House Biosimilar Discount Agreements 2026 - 19 - Denosumab (strength 60mg)

Original Deutschland - Arzneimittel - Open House Biologika Rabattverträge 2026 - 19 - Denosumab (Wirkstärke 60mg)

Open Contract notice

Key facts

Closes in
428 days
Where
Germany Hamburg
Procedure
Open procedure Anyone may submit a bid, in one step, with no pre-selection. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33600000 Pharmaceutical products
Original language
German
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 1 month ago
Notice number
354637-2026
Watch this tender

If the deadline moves or the notice is corrected, we email you. Log in

  1. Published
  2. Today
  3. Deadline open for 553 days
  4. Awarded pending

Summary

Machine-generated summary

TK (Techniker Krankenkasse), a German statutory health insurer based in Germany, is concluding discount agreements under Section 130a(8) SGB V for the active ingredient Denosumab at a strength of 60mg. The procedure is an Open House process: all suitable pharmaceutical entrepreneurs may participate, uniform conditions apply to everyone, no individual negotiations are conducted, and no exclusivity is granted to any partner. Contracts run for a maximum of 17 months starting on 01.07.2026 and end no later than 30.11.2027 regardless of the signing date. No contract value is stated. Further details are available in the participation and contract documents.

Description

Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Denosumab (Wirkstärke 60mg) zu schließen. Der Vertragsschluss erfolgt im Rahmen des Open-House-Verfahrens der TK: Individuelle Verhandlungen über Vertragsinhalte werden nicht geführt, es gelten einheitliche Konditionen. Die TK sichert einzelnen Vertragspartnern keine Exklusivität zu. Die Vertragslaufzeit beträgt maximal 17 Monate beginnend mit dem 01.07.2026. Der Vertrag endet spätestens am 30.11.2027, unabhängig vom Datum des Vertragsschlusses. Alle weiteren Informationen sind den Teilnahme- und Vertragsunterlagen zu entnehmen.

Can I bid?

  • Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
  • The notice is written in German.
  • Certificates from another EU country? Check the equivalents on eCertis

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

More from this buyer

Full buyer profile

52 open tenders right now

This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Germany

Company Wins Total awarded Last win
Siemens Healthineers AG 42 €17.4M Sep 2026
Philips GmbH 20 €5.3M Sep 2026
GlaxoSmithKline GmbH & Co. KG 15 n/a Sep 2026
ASTRAZENECA GMBH 12 n/a Jul 2026
Brainlab Sales GmbH 10 €4.0M Sep 2026

Based on 1018 awards with a linked company profile over the last 2 years.

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,101,350
9,621 open across Europe right now
Buyer track record on Aperlena
55 notices tracked · 0 awarded

Never miss a tender like this

58 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

428 days left

Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close